OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, synthesis, and biological characterization of proteolysis targeting chimera (PROTACs) for the ataxia telangiectasia and RAD3-related (ATR) kinase
Abdallah M. Alfayomy, Ramy Ashry, Anita G. Kansy, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116167-116167
Open Access | Times Cited: 7
Abdallah M. Alfayomy, Ramy Ashry, Anita G. Kansy, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116167-116167
Open Access | Times Cited: 7
Showing 7 citing articles:
Recent Progress in DNA Damage Response-Targeting PROTAC Degraders
Binbin Cheng, Xiaoting Fei, Zongbao Ding, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 6906-6921
Closed Access | Times Cited: 6
Binbin Cheng, Xiaoting Fei, Zongbao Ding, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 6906-6921
Closed Access | Times Cited: 6
Targeting Cellular DNA Damage Response in Cancer and Bacterial Infections: Current Progress, Challenges, and Opportunities
Rongbo Lin, Xu Zhang, Qinwei Zhu, et al.
(2025), pp. 3-3
Closed Access
Rongbo Lin, Xu Zhang, Qinwei Zhu, et al.
(2025), pp. 3-3
Closed Access
Rapid and high-throughput screening of proteolysis targeting chimeras using a dual-reporter system expressing fluorescence protein and luciferase
Shuai Meng, Yuan Meng, Xuena Yang, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access
Shuai Meng, Yuan Meng, Xuena Yang, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access
Probing Class I Histone Deacetylases (Hdac) with Proteolysis Targeting Chimera (Protac) for the Development of Highly Potent and Selective Degraders
Hany S. Ibrahim, Menglu Guo, Sebastian Hilscher, et al.
(2024)
Closed Access
Hany S. Ibrahim, Menglu Guo, Sebastian Hilscher, et al.
(2024)
Closed Access
Next-Generation Cancer Therapeutics: PROTACs and the Role of Heterocyclic Warheads in Targeting Resistance
Effat Omar, Rajendiran Rajesh, Pronoy Kanti Das, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117034-117034
Closed Access
Effat Omar, Rajendiran Rajesh, Pronoy Kanti Das, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117034-117034
Closed Access
Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells
Anita G. Kansy, Ramy Ashry, Al‐Hassan M. Mustafa, et al.
Molecular Oncology (2024) Vol. 18, Iss. 8, pp. 1958-1965
Open Access
Anita G. Kansy, Ramy Ashry, Al‐Hassan M. Mustafa, et al.
Molecular Oncology (2024) Vol. 18, Iss. 8, pp. 1958-1965
Open Access
Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degraders
Hany S. Ibrahim, Menglu Guo, Sebatian Hilscher, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107887-107887
Open Access
Hany S. Ibrahim, Menglu Guo, Sebatian Hilscher, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107887-107887
Open Access
